WebJun 1, 2024 · This is further complicated by the varying dosages of HiDAC. As a case in point, our patient suffered severe hepatotoxicity at an empirically reduced dose for her … WebApr 15, 2024 · A 63-year-old woman developed mucormycosis during treatment with cytarabine, daunorubicin for acute monocytic leukaemia and iron for anaemia [ dosages …
Cytarabine - StatPearls - NCBI Bookshelf
WebCancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL) Intent: Curative Regimen Category: evidence-informed Drugs Used: DOXOrubicin, vinCRIStine, dexamethasone, mercaptopurine, pegaspargase, Show More Funding: ODB - General Benefit ODB - General Benefit New Drug Funding Program Table of Contents DANAFARBERINT … WebStudy with Quizlet and memorize flashcards containing terms like Methrotrexate, Fluorouracil, Cytarabine and more. 46 terms · Methrotrexate → -Myelosuppression -Increased l…, Fluorouracil → -Coronary vasospasm -Hand-foot…, Cytarabine → -Hepatotoxicity -Neurological…, Gemcitabine → -rash -Flu-like syndrome, Purine … d1s hid led
Drug Induced Liver Injury Rank (DILIrank) Dataset FDA
WebDec 2, 2016 · The 30- and 60-day mortality rates were 0% and 7%, respectively. Of the 40 efficacy evaluable patients, best responses include 24 CR (60%), 7 CRi (18%), and 4 morphologic leukemia-free state (10%) with a CR+CRi (CRc) rate of 78%; 94% of CR or CRi responses occurred with 1 cycle of induction therapy. WebDec 2, 2016 · Cytarabine (Ara C) is considered the most effective chemotherapeutic agent in acute myeloid leukemia (AML) treatment. Several studies suggest that single nucleotide polymorphisms (SNPs) within the genes involving metabolic pathway of Ara C could influence in treatment outcomes, although their clinical relevance remains undetermined. … WebIntermittent high-dose cytarabine (3 g/m2 in 8 to 12 doses) is extremely myelosuppressive. Similarly, the gastrointestinal toxicity is formidable and dose-limiting. Severe, and … bingley angling club waters